Search

everythinglearnresearchcommunity

for

Search:↓

The vitamin D receptor is essential for skin stem cells to grow, move, and become different cell types needed for skin healing.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

New understanding of the causes of primary cicatricial alopecia has led to better diagnosis and potential new treatments.

Engineered skin substitutes can grow hair but have limitations like missing sebaceous glands and hair not breaking through the skin naturally.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Loss of Fz6 disrupts hair follicle and associated structures' orientation.

A mutation in the Soat1 gene causes hair structure defects and other health issues in AKR/J mice.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

The conclusion is that primary scarring alopecia is a complex condition that requires early and accurate diagnosis for effective treatment.

Deleting the Far2 gene in mice causes sebaceous gland issues and patchy hair loss.

A specific group of slow-growing stem cells marked by Thy1 is crucial for skin maintenance and healing in mice.

Two mouse mutations cause similar hair loss despite different skin changes.

A specific type of skin cell creates an opening for hair to grow out, and problems with this process can lead to skin conditions.

The conclusion is that analyzing RNA from skin oils is a promising way to understand skin diseases.

Three dogs with a rare skin condition improved with treatment.

The document concludes that scalp health is influenced by complex factors affecting sebaceous glands, including hormones, aging, and various substances.

Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.

Two new mutations in the CDH3 gene cause hair loss and vision problems in a young girl.

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Finasteride may help treat chronic CSC, improving vision.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

The committee decided not to approve the drug due to low effectiveness and high risks.

People with the same genetic mutation for Woodhouse-Sakati syndrome can have different symptoms.

The document concludes that managing Dunnigan-Type Familial Partial Lipodystrophy involves treating associated health issues and using medications like metformin and leptin replacement.

Genetic testing is crucial for diagnosing and treating acrodermatitis enteropathica effectively.

Statins may help treat alopecia areata by reducing harmful immune interactions.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.